Field clinical study evaluating the efficacy and safety of an oral formulation containing milbemycin oxime/praziquantel (Milbemax®, Novartis Animal Health) in the chemoprevention of the zoonotic canine infection by Dirofilaria repens

Field clinical study evaluating the efficacy and safety of an oral formulation containing milbemycin oxime/praziquantel (Milbemax®, Novartis Animal Health) in the chemoprevention of the zoonotic canine infection by Dirofilaria repens

Abstract Background Dirofilaria repens is the causative agent of subcutaneous dirofilariosis of dogs, other animals and humans. This nematode is transmitted by mosquitoes of Aedes, Anopheles and Culex genera. In dogs, the parasite may cause subclinical infection or cutaneous signs. Recently, D. repe...

Full description

Bibliographic Details
Main Authors: Angela Di Cesare, Gabriele Braun, Emanuela Di Giulio, Barbara Paoletti, Vincenzo Aquilino, Roberto Bartolini, Francesco La Torre, Silvana Meloni, Jason Drake, Federico Pandolfi, Stefania Avolio, Donato Traversa
Format: Article
Language:English
Published: BMC 2014-07-01
Series:Parasites & Vectors
Subjects:
Dirofilaria repens
Milbemycin oxime
Prevention
Dog
Italy
Online Access:https://doi.org/10.1186/1756-3305-7-347

Internet

https://doi.org/10.1186/1756-3305-7-347

Similar Items